155 related articles for article (PubMed ID: 25135188)
1. Mapping of the chromosomal amplification 1p21-22 in bladder cancer.
Scaravilli M; Asero P; Tammela TL; Visakorpi T; Saramäki OR
BMC Res Notes; 2014 Aug; 7():547. PubMed ID: 25135188
[TBL] [Abstract][Full Text] [Related]
2. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
[TBL] [Abstract][Full Text] [Related]
4. Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
López V; González-Peramato P; Suela J; Serrano A; Algaba F; Cigudosa JC; Vidal A; Bellmunt J; Heredero O; Sánchez-Carbayo M
J Transl Med; 2013 Aug; 11():182. PubMed ID: 23914742
[TBL] [Abstract][Full Text] [Related]
5. Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
Kanemoto K; Fukuta K; Kawai N; Tozawa K; Ochiai M; Okamoto K; Ohnami S; Sakamoto H; Yoshida T; Kanai Y; Katoh M; Yasui T; Kohri K; Kakizoe T; Nakagama H
PLoS One; 2016; 11(11):e0167374. PubMed ID: 27902773
[TBL] [Abstract][Full Text] [Related]
6. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
[TBL] [Abstract][Full Text] [Related]
7. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
8. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.
Melchor L; Saucedo-Cuevas LP; Muñoz-Repeto I; Rodríguez-Pinilla SM; Honrado E; Campoverde A; Palacios J; Nathanson KL; García MJ; Benítez J
Breast Cancer Res; 2009; 11(6):R86. PubMed ID: 19995430
[TBL] [Abstract][Full Text] [Related]
10. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
[TBL] [Abstract][Full Text] [Related]
11. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
[TBL] [Abstract][Full Text] [Related]
12. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
[TBL] [Abstract][Full Text] [Related]
13. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
[TBL] [Abstract][Full Text] [Related]
14. AMY2A: a possible tumor-suppressor gene of 1p21.1 loss in gastric carcinoma.
Kang JU; Koo SH; Kwon KC; Park JW
Int J Oncol; 2010 Jun; 36(6):1429-35. PubMed ID: 20428766
[TBL] [Abstract][Full Text] [Related]
15. TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
Zheng M; Simon R; Mirlacher M; Maurer R; Gasser T; Forster T; Diener PA; Mihatsch MJ; Sauter G; Schraml P
Am J Pathol; 2004 Jul; 165(1):63-9. PubMed ID: 15215162
[TBL] [Abstract][Full Text] [Related]
16. Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.
Del Rey J; Prat E; Ponsa I; Lloreta J; Gelabert A; Algaba F; Camps J; Miró R
BMC Cancer; 2010 Jun; 10():280. PubMed ID: 20540739
[TBL] [Abstract][Full Text] [Related]
17. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
19. A palindrome-mediated mechanism distinguishes translocations involving LCR-B of chromosome 22q11.2.
Gotter AL; Shaikh TH; Budarf ML; Rhodes CH; Emanuel BS
Hum Mol Genet; 2004 Jan; 13(1):103-15. PubMed ID: 14613967
[TBL] [Abstract][Full Text] [Related]
20. 6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
Shen H; Morrison CD; Zhang J; Underwood W; Yang N; Frangou C; Eng K; Head K; Bollag RJ; Kavuri SK; Rojiani AM; Li Y; Yan L; Hill A; Woloszynska-Read A; Wang J; Liu S; Trump DL; Candace JS
Oncotarget; 2013 Nov; 4(11):2124-34. PubMed ID: 24231253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
